Interleukin-10 of red nucleus plays anti-allodynia effect in neuropathic pain rats with spared nerve injury

Neurochem Res. 2012 Aug;37(8):1811-9. doi: 10.1007/s11064-012-0795-0. Epub 2012 May 15.

Abstract

Our previous studies have shown that pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β) in red nucleus (RN) are involved in the development of neuropathic pain and play facilitated roles on the mechanical allodynia induced by peripheral nerve injury. The current study was designed to evaluate the expression and effect of IL-10, an anti-inflammatory cytokine, in the RN of rats with spared nerve injury (SNI). Immunohistochemical staining results demonstrated when 3 weeks after SNI, the expression level of IL-10 in the contralateral RN of SNI rats was apparently higher than those of sham-operated and normal rats. To further study the effect of IL-10 in the development of neuropathic pain, different doses of IL-10 (1.0, 0.5 and 0.1 μg/μl) were microinjected respectively into the RN contralateral to the nerve injury side of SNI rats. Results demonstrated that higher doses of IL-10 (1.0 and 0.5 μg/μl) significantly attenuated the mechanical allodynia of neuropathic rats, while 0.1 μg/μl of IL-10 did not show any analgesic effect. These results suggest that IL-10 of RN participates in the development of neuropathic pain and plays inhibitory roles on the mechanical allodynia induced by SNI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hyperalgesia / metabolism
  • Hyperalgesia / prevention & control*
  • Interleukin-10 / administration & dosage*
  • Interleukin-10 / biosynthesis
  • Neuralgia / etiology*
  • Neuralgia / metabolism
  • Rats
  • Red Nucleus / metabolism
  • Sciatic Neuropathy / physiopathology

Substances

  • Interleukin-10